Contact Information

Currently Enrolling Trials

General Information

Clonazepam has been approved as an anticonvulsant to be manufactured in 0.5mg, 1mg and 2mg tablets. It is the generic equivalent of Roche Laboratories' Klonopin.

Approval Date: 1998-01-01

Company Name: Watson Pharmaceuticals

Back to Listings

22Sep
Spreadsheet Validation: Best Practices to Maintain Compliance
28Sep
4th Annual WCG MCC Clinical Trial Risk & Performance Management Collaborative vSummit
12Oct
Effective Root Cause Analysis and CAPA Investigations for the Life Sciences
18Oct
MAGI's Clinical Research vConference — Fall 2021
16Nov
16th Annual FDA Inspections vSummit

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here

Clonazepam

Profile

Contact Information

Currently Enrolling Trials

General Information

Upcoming Events

Spreadsheet Validation: Best Practices to Maintain Compliance

4th Annual WCG MCC Clinical Trial Risk & Performance Management Collaborative vSummit

Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

MAGI's Clinical Research vConference — Fall 2021

16th Annual FDA Inspections vSummit

Featured Products

Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

New ICH Standards Will Require Shift in Industry Thinking, Experts Say

European Trials Lag Behind U.S. in Decentralization, Survey Finds

Sites Face Tighter Imaging Needs for Certain Trials as Use of Imaging Keeps Climbing

Ask the Experts: Questions about Advertising for Clinical Trials

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.